Introduced
by
To create a government “prescription drug pricing board and prescription drug affordability stakeholder council” comprised of political appointees and individuals representing various interests, with the power to impose “upper payment limit” price controls on prescription drugs that a “prescription drug product purchaser or third-party payer” (insurers and social welfare agencies) would be prohibited from purchasing, billing-for, or reimbursing. The bill would also create a state “prescription drug affordability fund” but does not specify how this money would be used.
Referred to the Committee on Health Policy
